News Release

Notice of Manufacturing and Marketing Approval Application for "ROH-101 (Ganciclovir Eye Drops Gel)," a Treatment for Cytomegalovirus Corneal Endotheliitis

Rohto's Recruitment and Work Style Real Report 2026: Aiming for Co-Growth of Individuals and the Company

Izumiotsu City x Rohto Pharmaceutical "Kodomo MY Mirai Ai Project": Three Eye Care Model Schools Selected

Rohto Group's proprietary ingredient, "Licorice Extract Powder (Lyconin®)," which contains the ingredient gliasperin B, has been approved as a functional food product for the first time in Japan.

Three new products from "Eu Yan Sang" will be released sequentially.

What determines whether you "like" a skincare product? A follow-up report: Exploring the relationship between changes in the feel of Gokujun and physiological indicators.

We have successfully constructed a next-generation artificial skin model attached to blood vessels that exhibits cellular diversity.

The impact of the digital age on "eye problems" and "eye aging," as well as its "correlation with skin," has also been revealed!

Announcement of the establishment of the "Integrated Science and Social Collaboration Course on Food Wellbeing" by Rohto Pharmaceutical Co., Ltd. and the University of Tokyo.

Rohto Children's Dream Fund has selected nine organizations as recipients for its third round of grants.